US › Healthcare

Cerus Corporation (CERS)

US · Healthcare · Medical Devices

$2.19+1.86%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$57.4M
Revenue YoY
+9.5%
Net profit
$-2.9M
Profit YoY
+48.5%
EPS
$-0.01
EPS estimate
$-0.01
Net margin
-5.1%

EPS came in at -0.01 against a street estimate of -0.01 — a beat of 0.0%.

Key statistics

Market cap
$433.3M
Forward P/E
0.0
P/B
6.19
Book value
$0.35
EPS (TTM)
$-0.03
52-week high
$3.47
52-week low
$1.15
50-day MA
$2.86
200-day MA
$2.23
Beta
1.77

Analyst view

Analysts rate Cerus Corporation a strong buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $4.50.

Shareholding

Insiders
3.67%
Institutions
72.74%

Largest institutional holders

FundStake
BlackRock Inc10.71%
ARK Investment Management LLC9.51%
Soleus Capital Management, L.P.5.34%
Baker Bros Advisors LP4.97%
Vanguard Capital Management, LLC4.04%
Geode Capital Management, LLC2.30%
Amova Asset Management Americas, Inc2.24%
Sumitomo Mitsui Trust Group Inc2.24%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cerus Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.